Aglycosylated full-length IgG antibodies: steps toward next-generation immunotherapeutics

- Aglycosylated IgGs are nearly identical to glycosylated IgGs in terms of antigen binding.
- Significant progress has been made to enhance production of aglycosylated IgGs.
- Engineered aglycosylated Fc domains would be useful in therapeutic applications.